Literature DB >> 25820701

Decreased expression of claudin-3 is associated with a poor prognosis and EMT in completely resected squamous cell lung carcinoma.

Juanjuan Che1, Yifan Yang, Jing Xiao, Pengfei Zhao, Bo Yan, Shuo Dong, Bangwei Cao.   

Abstract

The deregulation of claudin-3 has been reported to correlate with the invasion and metastasis of various cancers, but little is known about its expression level and the prognostic value in squamous cell lung carcinoma (SqCC). The purpose of this study is to determine the expression levels and the prognostic value of claudin-3 in completely resected SqCC tissues, and the potential underlying mechanism. The protein expression of claudin-3, E-cadherin, β-catenin, and vimentin in the tumor tissues from 103 patients with surgically resected SqCC was examined using immunohistochemistry, western blots, as well as semi-quantitative estimation. The claudin-3 protein level was significantly associated with E-cadherin, β-catenin, and vimentin protein expression. A decreased claudin-3 protein level was significantly correlated with TNM stage, lymph node metastasis, and disease recurrence. Similarly, downregulation of E-cadherin was significantly correlated with lymph node metastasis and disease recurrence. Decreased β-catenin expression also had a significant correlation with disease recurrence. Univariate analyses indicated that the T stage, lymph node metastasis, the TNM stage, and the expression of claudin-3, β-catenin, and vimentin were significant predictors for overall survival (OS). Moreover, multivariate analyses demonstrated that the TNM stage and protein levels of claudin-3, β-catenin, and vimentin were independent predictors for OS of SqCC patients. Claudin-3 plays an important role in the epithelial-mesenchymal transition of SqCC and might be used as a potential prognostic factor for SqCC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25820701     DOI: 10.1007/s13277-015-3350-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  41 in total

1.  Twist1 causes the transcriptional repression of claudin-4 with prognostic significance in esophageal cancer.

Authors:  Keun-Woo Lee; Nam Kyung Lee; Jeong Hoon Kim; Myung Soo Kang; Hae Yong Yoo; Hyeon Ho Kim; Sung Hee Um; Seok-Hyung Kim
Journal:  Biochem Biophys Res Commun       Date:  2012-06-02       Impact factor: 3.575

Review 2.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

Review 3.  Biology of claudins.

Authors:  Susanne Angelow; Robert Ahlstrom; Alan S L Yu
Journal:  Am J Physiol Renal Physiol       Date:  2008-05-14

4.  The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers.

Authors:  Masaki Tokumo; Shinichi Toyooka; Katsuyuki Kiura; Hisayuki Shigematsu; Kunitoshi Tomii; Motoi Aoe; Kouichi Ichimura; Toshihide Tsuda; Masaaki Yano; Kazunori Tsukuda; Masahiro Tabata; Hiroshi Ueoka; Mitsune Tanimoto; Hiroshi Date; Adi F Gazdar; Nobuyoshi Shimizu
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

5.  Expression of E-cadherin and lymph node metastasis in resected non-small-cell lung cancer.

Authors:  T Hirata; T Fukuse; H Naiki; H Wada
Journal:  Clin Lung Cancer       Date:  2001-11       Impact factor: 4.785

6.  Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma.

Authors:  Yu-Chih Chao; Szu-Hua Pan; Shuenn-Chen Yang; Sung-Liang Yu; Ting-Fang Che; Chung-Wu Lin; Mu-Shiun Tsai; Gee-Chen Chang; Che-Hsiang Wu; Yi-Ying Wu; Yung-Chie Lee; Tse-Ming Hong; Pan-Chyr Yang
Journal:  Am J Respir Crit Care Med       Date:  2008-09-11       Impact factor: 21.405

Review 7.  Targeted therapies for non-small cell lung cancer.

Authors:  Wolfram C M Dempke; Tamas Suto; Martin Reck
Journal:  Lung Cancer       Date:  2009-11-14       Impact factor: 5.705

8.  Distinct claudin expression profile in histologic subtypes of lung cancer.

Authors:  Judit Moldvay; Márta Jäckel; Csilla Páska; Ibolya Soltész; Zsuzsa Schaff; András Kiss
Journal:  Lung Cancer       Date:  2007-04-06       Impact factor: 5.705

9.  TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma.

Authors:  M E Kupferman; T Jiffar; A El-Naggar; T Yilmaz; G Zhou; T Xie; L Feng; J Wang; F C Holsinger; D Yu; J N Myers
Journal:  Oncogene       Date:  2010-01-18       Impact factor: 9.867

10.  Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung.

Authors:  Ludmila Prudkin; Diane D Liu; Natalie C Ozburn; Menghong Sun; Carmen Behrens; Ximing Tang; Kathlynn C Brown; B Nebiyou Bekele; Cesar Moran; Ignacio I Wistuba
Journal:  Mod Pathol       Date:  2009-03-06       Impact factor: 7.842

View more
  14 in total

Review 1.  Claudins in morphogenesis: Forming an epithelial tube.

Authors:  Amanda I Baumholtz; Indra R Gupta; Aimee K Ryan
Journal:  Tissue Barriers       Date:  2017-08-24

2.  Increased expression of monoamine oxidase A is associated with epithelial to mesenchymal transition and clinicopathological features in non-small cell lung cancer.

Authors:  Fei Liu; Liang Hu; Yuefan Ma; Bingyu Huang; Zihan Xiu; Peihua Zhang; Keyuan Zhou; Xudong Tang
Journal:  Oncol Lett       Date:  2017-12-21       Impact factor: 2.967

3.  [Claudin-3 expression in colorectal carcinoma and its significance].

Authors:  Jing-Yi Li; Fang Xie; Xiao-Ping Xu; Juan-Juan Ma; Dai-Chao Zhou; Yan Liao; Jing Tang; Qian Xie; Lan Bai; Qing-Zhen Nan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-01-20

4.  Ubiquitin-Conjugating Enzyme E2T is an Independent Prognostic Factor and Promotes Gastric Cancer Progression.

Authors:  Hao Yu; Pei Xiang; Qi Pan; Yijiao Huang; Nanlan Xie; Weimin Zhu
Journal:  Tumour Biol       Date:  2016-03-28

5.  Platelet microparticle-mediated transfer of miR-939 to epithelial ovarian cancer cells promotes epithelial to mesenchymal transition.

Authors:  Meiling Tang; Lu Jiang; Yingying Lin; Xiaoli Wu; Kai Wang; Qizhi He; Xipeng Wang; Weiping Li
Journal:  Oncotarget       Date:  2017-10-27

6.  Claudin-3 Inhibits Lung Squamous Cell Carcinoma Cell Epithelial-mesenchymal Transition and Invasion via Suppression of the Wnt/β-catenin Signaling Pathway.

Authors:  Juanjuan Che; Dongsheng Yue; Bin Zhang; Hua Zhang; Yansong Huo; Liuwei Gao; Hongchao Zhen; Yan Yang; Bangwei Cao
Journal:  Int J Med Sci       Date:  2018-02-05       Impact factor: 3.738

7.  Claudin-3 expression increases the malignant potential of lung adenocarcinoma cells: role of epidermal growth factor receptor activation.

Authors:  Lianmin Zhang; Yuan Wang; Bin Zhang; Hua Zhang; Meng Zhou; Mei Wei; Qiuping Dong; Yue Xu; Zhaosong Wang; Liuwei Gao; Yanjun Qu; Bowen Shi; Jinfang Zhu; Yuesong Yin; Yulong Chen; Lu Sun; Wei Zhang; Shilei Xu; Guoguang Ying; Changli Wang
Journal:  Oncotarget       Date:  2017-04-04

8.  Decreased expression of Dlg5 is associated with a poor prognosis and epithelial-mesenchymal transition in squamous cell lung cancer.

Authors:  Juanjuan Che; Jing Wang; Huihui Li; Hongchao Zhen; Kun Shang; Yan Yang; Bangwei Cao
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 2.895

9.  Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases.

Authors:  Zhihua Ye; Xin Zhang; Yihuan Luo; Shikang Li; Lanshan Huang; Zuyun Li; Ping Li; Gang Chen
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

10.  Gene expression profiling to predict recurrence of advanced squamous cell carcinoma of the tongue: discovery and external validation.

Authors:  Tomohiro Enokida; Satoshi Fujii; Mari Takahashi; Youichi Higuchi; Shogo Nomura; Tetsuro Wakasugi; Tomoko Yamazaki; Ryuichi Hayashi; Atsushi Ohtsu; Makoto Tahara
Journal:  Oncotarget       Date:  2017-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.